← Leaderboards
Abraham Jacob
Washington University
$1,223,660
Attributed
$1,223,660
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.2K · FY2009–13$250K$187.5K$125K$62.5K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,223,660 · 2
By mechanism
K08$1,161,160 · 1
R03$62,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- David H. Gutmann$29,869,613
- Michael L. McDaniel$8,357,916
- Jason Weber$7,135,661
- Gay R Holstein$10,818,300
- Stephen Morris Highstein$6,736,357
Others in their field
Top investigators on “1-Phosphatidylinositol 3-Kinase”
- Thomas M Roberts · Dana-Farber Cancer Institute$16,400,107
- Lewis C Cantley · Beth Israel Deaconess Medical Center$13,772,954
- Peter K Vogt · Scripps Research Institute$8,861,088
- Garth Powis · University Of Arizona$8,434,094
- Jonathan M. Backer · Yeshiva University$7,716,313
- Zhenyu Yue · Icahn School Of Medicine At Mount Sinai$7,443,603
Research focus
1-Phosphatidylinositol 3-KinaseAftercareAlternative TreatmentAcoustic NeuromaAnimalsAntibodiesApoptosisBehavior AssessmentBenchmarkingBilateral Vestibular SchwannomaBioavailableBiological Adaptation To StressBlindnessBlood - Brain Barrier AnatomyBlood Chemical AnalysisCareer DevelopmentCaspaseCell CycleCell Cycle RegulationCell DeathCell ProliferationCellsCell SurvivalCessation Of Life
Grant awards (6)
Preclinical testing of a novel PDK1 inhibitor for treating vestibular schwannoma$232,232
K08 · FY2013 · DC · contact PI
Preclinical testing of a novel PDK1 inhibitor for treating vestibular schwannoma$232,232
K08 · FY2012 · DC · contact PI
Preclinical testing of a novel PDK1 inhibitor for treating vestibular schwannoma$232,232
K08 · FY2011 · DC · contact PI
Preclinical testing of a novel PDK1 inhibitor for treating vestibular schwannoma$232,232
K08 · FY2010 · DC · contact PI
Preclinical testing of a novel PDK1 inhibitor for treating vestibular schwannoma$232,232
K08 · FY2009 · DC · contact PI
Nitric Oxide and Chronic Rhinosinusitis$62,500
R03 · FY2001 · DC